LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.86 | 84.90 | 1 | 7680 | 0.0001 | -0.4951 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.86 | 84.90 | 79 | 7680 | 0.0103 | -0.0110 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.86 | 84.90 | 1 | 7680 | 0.0001 | -0.4951 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 87.86 | 84.90 | 3422 | 7680 | 0.4456 | 0.7661 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 89.57 | 84.90 | 1 | 7494 | 0.0001 | -0.4970 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 89.57 | 84.90 | 31 | 7494 | 0.0041 | -0.1443 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 89.57 | 84.90 | 1 | 7494 | 0.0001 | -0.4970 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 89.57 | 84.90 | 2216 | 7494 | 0.2957 | 0.6564 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 5 | 7420 | 0.0007 | -0.3554 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 91.27 | 84.90 | 805 | 7420 | 0.1085 | 0.4173 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.98 | 84.90 | 1 | 7257 | 0.0001 | -0.4995 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.98 | 84.90 | 1 | 7257 | 0.0001 | -0.4995 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.98 | 84.90 | 1 | 7257 | 0.0001 | -0.4995 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 92.98 | 84.90 | 276 | 7257 | 0.0380 | 0.2017 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 84.90 | 1 | 7000 | 0.0001 | -0.5023 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 94.68 | 84.90 | 40 | 7000 | 0.0057 | -0.1115 | MN20160318_Q02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.66 | 84.90 | 2 | 285 | 0.0070 | -0.8824 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.66 | 84.90 | 512 | 285 | 1.7919 | 1.7906 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 2.66 | 84.90 | 640 | 285 | 2.2398 | 2.1699 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | E17 |